The Key to Building a Vibrant Biosimilars Marketplace

Despite the enormous promise that biosimilar drugs hold for increasing patient access to care and bringing down costs, surveys show that too many in the medical community are unaware of the benefits they offer. But a new Food and Drug Administration (FDA) awareness campaign aimed at educating doctors, patients and other stakeholders about the safety and effectiveness of these critical, life-saving drugs could be key to building a more robust biosimilars marketplace in the U.S.